Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-22-060498

Chief Operating Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Keuer Thomas A Chief Operating Officer 2022-12-08 Grant or award +40,000 40,730 D
Loading xslF345X03/doc4.xml…